Investors

Sinclair Annual Report and Accounts 2016

View and download the Sinclair Pharma plc Report & Accounts for 2016

Download Annual Report (PDF)

Latest News and Market Press Releases

Sinclair and ThermiGen terminate US distribution agreement

Sinclair Pharma plc (AIM:SPH.L) (“Sinclair” or the “Group”), the international aesthetics company, announces that its contract with ThermiGen LLC (“Thermi”), an Almirall SA company, for the sale and distribution of Silhouette InstaLift™, Silhouette Refine™ and Silhouette Lift®

Ellansé Approved for Brazil

Sinclair Pharma plc (AIM:SPH.L) (“Sinclair” or the “Group”), the international aesthetics company, is pleased to announce that it has received regulatory approval of Ellansé® by ANVISA in Brazil.

Investor News

Read our latest Investor News and find out about financial and general topics of Sinclair Pharma Plc.

View all news

Company Profile

A pure-play investment in the high growth multi-billion dollar global aesthetics market with supportive macro dynamics driving demand and acceptance.

Read more

GBP 17.50

-0.25(-1.41%)

View Stock

  • Latest Price: 17.50p
  • Day High: 18.80p
  • Last Close: 17.75p
  • Day low: 17.00p

Investor Relations and Media Contact

Andy Crane
Head of Communication

Tel: +44 (0)20 7467 6920
Fax: +44 (0)20 7467 6930
Email: ACrane@sinclairpharma.com

Financial Calendar

Year End
31st December 2018
Full Year Results for period to 31/12/17
April 2018
AGM
May 2018
Next Trading Update
July 2018
Next Interim Results Announcement
September 2018